TRIGLAV INVESTMENTS, D.O.O.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2056690
LJUBLJANA, 2A
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,870,620
-$447,300 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#531
of 1,322 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRIGLAV INVESTMENTS, D.O.O. holds $5,956,452 across 7 Biotechnology names. REGN ranks #1 (31.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,000 | $1,870,620 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,450 | $1,713,718 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
16,500 | $944,130 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
70,053 | $397,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,102 | $393,662 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
3,000 | $367,740 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,115 | $268,681 |
All Filings in REGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,870,620 | 3,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,317,920 | 3,000 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,315,610 | 3,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,686,810 | 3,000 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,320,375 | 2,515 | Shares | Sole | 2025-08-05 | |
| 2024-12-31 | $1,791,509 | 2,515 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||